Advertisement
Canada markets open in 28 minutes
  • S&P/TSX

    22,107.08
    +194.56 (+0.89%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CAD/USD

    0.7370
    -0.0003 (-0.04%)
     
  • CRUDE OIL

    82.66
    +1.31 (+1.61%)
     
  • Bitcoin CAD

    96,051.02
    +764.76 (+0.80%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,231.40
    +18.70 (+0.85%)
     
  • RUSSELL 2000

    2,114.35
    +44.19 (+2.13%)
     
  • 10-Yr Bond

    4.2200
    +0.0240 (+0.57%)
     
  • NASDAQ futures

    18,493.50
    -10.25 (-0.06%)
     
  • VOLATILITY

    13.00
    +0.22 (+1.72%)
     
  • FTSE

    7,953.55
    +21.57 (+0.27%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6817
    +0.0012 (+0.18%)
     

U.S. government to buy point-of-care COVID-19 tests from Abbott, Celltrion -source

Sept 21 (Reuters) - The U.S. government has agreed to purchase point-of care COVID-19 tests from Abbott Laboratories and Celltrion Inc to ship to nursing homes and other high risk populations as part of its broader plan to purchase $2 billion in rapid coronavirus tests, a person familiar with the matter said on Tuesday.

The federal government will purchase tests as needed and has agreed to spend up to $626 million in its agreement with Celltrion and $554.4 million in its deal with Abbott, the person said.

(Reporting by Carl O'Donnell Editing by Chris Reese)